Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: DELT1970 who wrote (9423)	6/4/1998 12:32:00 AM
From: Step1	Respond to of 14328

I am usually a lurker here, but just wanted to make a comment on the topic of P. Patience is inversely proportional to the entry point, the lower the entry point, the higher the level of patience. In my personal case I am willing and able to be quite patient on this one. Appreciate the quality of discussion on this thread. back to lurking mode sg

To: DELT1970 who wrote (9423)	6/4/1998 7:26:00 AM
From: Scott H. Davis	Read Replies (2) \| Respond to of 14328

Grobnette, thanks for the post. By any chance were there any more details discussed. Such as margins for 1tr1, or especially qtr1 98 vs 97 ? Same thing for SG&A. International news was welcome. I was serious in regards in looking for intermediate term catalysts. Could you double check your notes - are they now saying 50% EPS growth (before they were saying 30%, and not specific on revenue vs EPS) 30% was consistant with their .09 EPS target. 50% would be great if they can pull it off (unfortunately still way behind the gonzo analyst who is predicting 120% fy98 to fy99) You said no comment on FDA reasons. Was this due to nobody asking, or did they evade intentionally? Any clarifications would be appreciated. Scott (Eric W. where are you?)